Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis

European Respiratory Journal

Volumn 49, Issue 4, 2017, Pages

  Vallières, Emilie ^a,b,c   Tumelty, Karen ^c   Tunney, Michael M ^b,c   Hannah, Rosemary ^c   Hewitt, Oonagh ^c   Stuart Elborn, J ^a,b,c   Downey, Damian G ^b,c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; COLISTIMETHATE; ANTIINFECTIVE AGENT;

ADULT; AGED; BACTERIUM CULTURE; BRONCHIECTASIS; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE FREE INTERVAL; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; STANDARDIZATION; TREATMENT DURATION; COMPLICATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PSEUDOMONAS AERUGINOSA; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; AGED; ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; CIPROFLOXACIN; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TREATMENT OUTCOME;

EID: 85034635873     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00851-2016     Document Type: Letter

References (7)

1. Finch S, McDonnell MJ, Abo-Leyah H, et al. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc 2015; 12: 1602–1611.
2. Pasteur MC, Bilton D, Hill AT. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010; 65 Suppl 1: i1–i58.
3. Valerius NH, Koch C, Høiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991; 338: 725–726.
4. Orriols R, Hernando R, Ferrer A, et al. Eradication therapy against Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. Respiration 2015; 90: 299–305.
5. Wagner T, Soong G, Sokol S, et al. Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients. Chest 2005; 128: 912–919.
6. Lutz L, Pereira DC, Paiva RM, et al. Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm. BMC Microbiol 2012; 12: 196.
7. Ichimiya T, Takeoka K, Hiramatsu K, et al. The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro. Chemotherapy 1996; 42: 186–191.